심장 매핑 시장 규모, 점유율 및 성장 분석 : 유형별, 적응증별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cardiac Mapping Market size was valued at USD 2.16 Billion in 2024 and is poised to grow from USD 2.35 Billion in 2025 to USD 4.64 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

Market insights reveal that around 14 million people in the U.S. are affected by heart rhythm disorders, driving the growth of cardiac mapping systems as a sophisticated and non-invasive solution. This advanced technique collects electrical impulses from the chest, integrating them with data from computed tomography (CT) scans to produce high-quality cardiac maps. These intricate maps are essential for specialists as they analyze complex rhythm patterns of the heart. By utilizing cardiac mapping, healthcare professionals gain deeper insights into heart rhythm disorders, enabling more precise diagnoses and personalized treatment strategies. This innovation not only enhances patient care but also positions cardiac mapping as a critical tool in the realm of cardiology, signaling a significant trend in the management of heart health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Mapping Market Segments Analysis

Global Cardiac Mapping Market is segmented by Type, Indication, End User and region. Based on Type, the market is segmented into Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems. Based on Indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Mapping Market

The growth of the global cardiac mapping market is primarily driven by two significant factors: the increasing incidence of cardiovascular disorders and ongoing technological innovations in cardiac mapping diagnostics. Cardiovascular diseases are recognized as the primary cause of global mortality, leading to millions of deaths each year, with a considerable number of these fatalities resulting from heart attacks and strokes. This alarming trend highlights the urgent need for advanced diagnostic tools. As healthcare providers seek to improve patient outcomes, the demand for sophisticated cardiac mapping systems continues to rise, fostering further development and investment in this crucial sector.

Restraints in the Global Cardiac Mapping Market

One significant restraint influencing the Global Cardiac Mapping market is the growing complexity associated with cardiac imaging treatments. As the methodologies for diagnosing and managing cardiac conditions become more sophisticated, the need for advanced technologies and specialized skill sets intensifies. This complexity can create barriers for healthcare providers, particularly in terms of training and resource allocation, ultimately slowing down the widespread adoption of cardiac mapping techniques. Furthermore, the intricacies involved in integrating these advanced procedures into existing healthcare frameworks may lead to increased costs and potential challenges in maintaining streamlined workflows, thereby hindering market growth.

Market Trends of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is experiencing notable expansion, fueled by the rising demand for advanced cardiac diagnostic technologies. Innovations from medical device companies are at the forefront, enhancing the precision and efficiency of cardiac assessments. This trend is further propelled by an increasing awareness of cardiac health and the need for accurate testing methods among healthcare providers and patients alike. Additionally, the integration of advanced imaging techniques and artificial intelligence in cardiac mapping is driving improvements in patient outcomes and procedural efficiencies. As healthcare systems prioritize early detection and personalized treatment, the market is poised for significant growth in the foreseeable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Cardiac Mapping Market Size by Type & CAGR (2026-2033)

• Market Overview
• Contact Cardiac Mapping Systems
• Non-Contact Cardiac Mapping Systems

Global Cardiac Mapping Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Atrial Fibrillation
• Atrial Flutter
• Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
• Other Indications

Global Cardiac Mapping Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Other End Users

Global Cardiac Mapping Market Size & CAGR (2026-2033)

• North America (Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosig Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioInsight Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EP Solutions SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedLumics (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations